Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab

Abstract Introduction: Cardiac allograft vasculopathy (CAV) is a major limitation for long-term survival of patients undergoing heart transplantation (HT). Some immunosuppressants can reduce the risk of CAV. Objectives: The primary objective was to evaluate the variation in the volumetric growth of...

Full description

Bibliographic Details
Main Authors: Ricardo Wang, Lidia Ana Zytynski Moura, Sergio Veiga Lopes, Francisco Diniz Affonso da Costa, Newton Fernando Stadler Souza Filho, Tiago Luiz Fernandes, Natália Boing Salvatti, José Rocha Faria-Neto
Format: Article
Language:English
Published: Sociedade Brasileira de Cardiologia (SBC) 2015-01-01
Series:Arquivos Brasileiros de Cardiologia
Subjects:
Doenças Vasculares / fisiopatologia
Transplante Cardíaco
Anticorpos Monoclonais Murinos / administração & dosagem
Imunossupressores
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015005050063&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015005050063&lng=en&tlng=en

Similar Items